Patent · US Active

Circular nucleic acid vectors, and methods for making and using the same

US9745590B2 · kind B2 · utility

19Cited by
12References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 8, 2014
Grant dateAug 29, 2017
Priority date
Expiry dateSep 8, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Circular nucleic acid vectors that provide for persistently high levels of protein expression are provided. The circular vectors of the subject invention are characterized by being devoid of expression-silencing bacterial sequences, where in many embodiments the subject vectors include a unidirectional site-specific recombination product hybrid sequence in addition to an expression cassette. Also provided are methods of using the subject vectors for introduction of a nucleic acid, e.g., an expression cassette, into a target cell, as well as preparations for use in practicing such methods. The subject methods and compositions find use in a variety of different applications, including both research and therapeutic applications. Also provided is a highly efficient and readily scalable method for producing the vectors employed in the subject methods, as well as reagents and kits/systems for practicing the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.